Gen XY Updates from GlobeNewswire

2024-02-24T01:15:09Z
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 24, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today...


2024-02-24T01:15:00Z
Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) has approved...


2024-02-23T22:50:52Z
Company Announcement


2024-02-23T22:35:36Z
Company Announcement


2024-02-23T22:33:13Z
REDWOOD CITY, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective February 20, 2024, the compensation committee of the...


2024-02-23T22:10:00Z
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and...


2024-02-23T21:10:00Z
FLORHAM PARK, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Celularity, Inc. (Nasdaq: CELU; CELUW) (“Celularity”), a biotechnology company developing allogeneic cell therapies and advanced biomaterial products, today announced that its...


2024-02-23T21:05:00Z
NOVATO, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases,...


2024-02-23T21:05:00Z
MALVERN, Pa., Feb. 23, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical...


2024-02-23T21:05:00Z
PHOENIX, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today announced that it received a notice (“Notice”) on February 21, 2024 from...


2024-02-23T20:13:22Z
Research Reveals Mental Growth Directly Linked to Emotional Responses


2024-02-23T20:10:15Z
- Shareholders holding an aggregate of 47.15% of IBEX’s outstanding shares have entered into Support and Voting Agreements with the purchaser


2024-02-23T19:48:31Z
PARAMUS, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, today...


2024-02-23T17:45:35Z


2024-02-23T17:22:31Z
The Ibogaine Research Center is conducting comprehensive research on addiction treatments. The group, headed by David Dardashti, comprises specialists in organizational psychology (Gavriel Dardashti), Data Coordination (Cole Barressi), Harvard-trained psychiatrist...


2024-02-23T15:38:40Z
New Medical Cannabis Act in Germany Provides Easier Access to Medical Cannabis for Patients Through the MedCanG


2024-02-23T15:31:14Z
MIAMI, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Two executive leaders at VITAS Healthcare have been promoted to top operational roles. Joel Wherley now serves as president and chief operating officer...


2024-02-23T15:21:54Z
LOS ANGELES, Feb. 23, 2024 (GLOBE NEWSWIRE) --  Today, Curai Health, a virtual clinic, announced that it is expanding access to high-quality care for individuals experiencing homelessness. In collaboration with Healthcare...


2024-02-23T14:01:00Z
VALENCIA, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin...


2024-02-23T14:00:00Z
NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- (Strainsforpains, Inc.) (OTC Markets: EBYH).


2024-02-23T14:00:00Z


2024-02-23T14:00:00Z
EDMONTON, Alberta, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), today provided an update on its progress across its current business.


2024-02-23T13:50:00Z
Live webcast with Lori Bisson, Chief Executive Officer of Autonomix, on Thursday, February 29th at 12:00 PM ET


2024-02-23T13:30:00Z
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”)


2024-02-23T13:00:38Z
REDWOOD CITY, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117)...


2024-02-23T13:00:00Z
TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into...


2024-02-23T13:00:00Z
SIOUX FALLS, S.D., Feb. 23, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human...


2024-02-23T13:00:00Z
Expanded access program (EAP) data for omidubicel are consistent with Phase 3 trial results on rates of hematopoietic recovery and infections following stem cell transplant with Omisirge® (omidubicel-onlv)


2024-02-23T13:00:00Z
FARMINGTON HILLS, Mich., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment...


2024-02-23T12:30:00Z
Conference call to be held Wednesday, February 28, 2024, at 8:30 AM ET


2024-02-23T12:06:00Z
For the first time, patients with alcohol use disorder will receive the company's unique and proprietary psychedelic - MEAI


2024-02-23T12:05:39Z
Committee for Medicinal Products for Human Use (CHMP) recommends approval of the conditional marketing authorization (CMA) for sparsentan for the treatment of IgA nephropathy (IgAN) in Europe


2024-02-23T12:00:26Z
CAMBRIDGE, Mass., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a...


2024-02-23T12:00:00Z
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new analyses of real-world use of oral, once-daily ORLADEYO® (berotralstat) that showed patients who...


2024-02-23T11:58:00Z
Company Announcement no. 144 – 2024Copenhagen, February 23rd, 2024


2024-02-23T11:45:00Z
BETHESDA, Md., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM), a cybersecurity and software services company focused on the federal government, announces that it has closed its previously...


2024-02-23T11:22:53Z
Results from the Phase 3 CARTITUDE-4 study, which supported the CHMP recommendation, showed that cilta-cel has the potential to offer significant benefit to patients in earlier lines of treatment1


2024-02-23T07:30:00Z
This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail.


2024-02-23T07:00:00Z
Press Release


2024-02-23T07:00:00Z
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced microbial platforms for...


2024-02-23T06:35:06Z
COPENHAGEN, Denmark, February 23, 2024 – Bavarian Nordic A/S (OMX: BAVA) (“the Company”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...


2024-02-23T06:00:00Z
Dupixent® sBLA accepted for FDA Priority Review for treatment of COPD with type 2 inflammation


2024-02-23T06:00:00Z
Priority Review granted based on positive results from two Phase 3 trials; if approved, Dupixent would be the only biologic therapy for COPD and the first new treatment approach for...


2024-02-23T01:00:54Z
Calgary-based low-cost airline will cease operations effective February 26


2024-02-22T23:57:16Z
MACAU, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC), a world-class integrated resort located in Cotai, Macau, today announces that it will release its unaudited...


2024-02-22T21:30:00Z
ADELAIDE, Australia and CAMBRIDGE, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to...


2024-02-22T21:30:00Z
BETHESDA, Md., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust, today provided an updated investor...


2024-02-22T21:24:05Z
WARSAW, Ind., Feb. 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the...


2024-02-22T21:15:00Z
ST. LOUIS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the first treatment of patients with a...


2024-02-22T21:15:00Z
Knoxville, Tennessee, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies, Inc. (“HiTC”), a leading innovator of healthcare technology solutions, is proud to announce the issuance of its second United...